TY - JOUR
T1 - Selection of high-affinity and high-specificity monoclonal antibodies for 1α,25-dihydroxyvitamin D
AU - Mawer, E. Barbara
AU - Berry, Jacqueline L.
AU - Bessone, Juana
AU - Shany, Shraga
AU - Smith, Hilary
AU - White, Anne
N1 - Funding Information:
This study was supported by awards to the Departments Pathology and Medicine from the North Western Regional Health (Research Infrastructure) and by a Project Grant awarded to Medical Research Council.
PY - 1985/1/1
Y1 - 1985/1/1
N2 - The preparation of high-affinity and high-specificity monoclonal antibodies to 1α,25-dihydroxyvitamin D is described. Monoclonal antibodies were derived from Balb-c mice immunised with either 1α-hydroxy-25,26,27-trinor-24-cholecalcioic acid or with 1α-hydroxy-26,27-dinor-chole-calciferol-25-oxime, and spleen cells were hybridised with mouse myeloma cells. From six fusions nine monoclonal antibodies (MAb's) were selected from 676 antibody-secreting hybrids. Antibodies varied widely in their ability to bind 1α,25-dihydroxyvitamin D3 (50% displacement of radioligand ranged from 25 - 900 pg); two had particularly useful characteristics for 1α,25-dihydroxyvitamin D assay. MAb 5F2 has high affinity (Ka = 1.39 × 1010M-1) and does not discriminate between 1α,25-dihydroxyvitamin D2 and D3, thus enabling the two forms to be measured together. MAb 1G7 is highly specific, having no cross-reactivity with 25-hydroxy-, 24,25-dihydroxy- or 25,26-dihydroxyvitamin D at concentrations found in normal human serum; this MAb has the potential to eliminate the lengthy extraction procedures involved in currently available assays for 1α,25-dihydroxyvitamin D.
AB - The preparation of high-affinity and high-specificity monoclonal antibodies to 1α,25-dihydroxyvitamin D is described. Monoclonal antibodies were derived from Balb-c mice immunised with either 1α-hydroxy-25,26,27-trinor-24-cholecalcioic acid or with 1α-hydroxy-26,27-dinor-chole-calciferol-25-oxime, and spleen cells were hybridised with mouse myeloma cells. From six fusions nine monoclonal antibodies (MAb's) were selected from 676 antibody-secreting hybrids. Antibodies varied widely in their ability to bind 1α,25-dihydroxyvitamin D3 (50% displacement of radioligand ranged from 25 - 900 pg); two had particularly useful characteristics for 1α,25-dihydroxyvitamin D assay. MAb 5F2 has high affinity (Ka = 1.39 × 1010M-1) and does not discriminate between 1α,25-dihydroxyvitamin D2 and D3, thus enabling the two forms to be measured together. MAb 1G7 is highly specific, having no cross-reactivity with 25-hydroxy-, 24,25-dihydroxy- or 25,26-dihydroxyvitamin D at concentrations found in normal human serum; this MAb has the potential to eliminate the lengthy extraction procedures involved in currently available assays for 1α,25-dihydroxyvitamin D.
UR - http://www.scopus.com/inward/record.url?scp=0022249413&partnerID=8YFLogxK
U2 - 10.1016/0039-128X(85)90054-6
DO - 10.1016/0039-128X(85)90054-6
M3 - Article
AN - SCOPUS:0022249413
SN - 0039-128X
VL - 46
SP - 741
EP - 754
JO - Steroids
JF - Steroids
IS - 2-3
ER -